Brief: Jade Biosciences Inc - Prospectus Filed For Resale Of Up To 39,542,339 Shares By Selling Stockholders - SEC Filing
15/05/2026 22:04
May 15 (Reuters) - Jade Biosciences Inc JBIO.O: JADE BIOSCIENCES INC - PROSPECTUS FILED FOR RESALE OF UP TO 39,542,339 SHARES BY SELLING STOCKHOLDERS - SEC FILING Source text: [ID:n0001193125-26-227051] Further company coverage: JBIO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jade Biosciences
See all newsBrief: Jade Biosciences Announces Preclinical Data Characterizing Jade301, A Potentially Best-In-Class, Half-Life-Extended Anti-Ifn-Β Monoclonal Antibody In Development For Dermatomyositis, At Eadv 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Jade Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Jade Biosciences Q2 net loss widens as costs rise
Brief: Jade Biosciences, Inc Q2 Cash & Investments USD 461.2 Million